The importance of removing interference caused by Darzalex® (daratumumab) in pre-transfusion testing. JHSCI [Internet]. 2024 Feb. 25 [cited 2024 Nov. 21];13(3 (Suplement 1):243-5. Available from: https://jhsci.ba/ojs/index.php/jhsci/article/view/2612